(IN BRIEF) The University of Liverpool and Imperial College London, working with international partners, have published the first global systematic review of hepatitis B care, commissioned by WHO and covering over 1.7 million patients across 50 countries. The analysis found … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Non Profit, Science, Technology, United Kingdom
Tagged Alexander Stockdale, antiviral therapy, chronic hepatitis B, decentralised healthcare, diagnosis gaps, global elimination target 2030, global health, Hepatitis B, HIV care models, Imperial College London, maternal health, partnership, Patient Retention, Philippa Easterbrook, postpartum care, primary care, The Lancet Gastroenterology & Hepatology, treatment initiation, University of Liverpool, WHO, World Health Organization
(IN BRIEF) An international team of researchers, including Empa scientists, is developing nanozymes to treat inflammation during pregnancy without harming the mother or fetus. These tiny particles, which have enzyme-like properties, could provide a safer alternative to traditional medications. Initial … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Switzerland, Technology
Tagged anti-inflammatory, antibacterial, biotechnology, Empa, Empa research, fetal health, Healthcare Innovation, human placental tissue, inflammation, maternal health, nanomedicines, nanotechnology, nanozymes, Nikolaos Tagaras, placenta chip, placental barrier, pregnancy complications, pregnancy research, prenatal care, safe treatment, Swiss National Science Foundation, Tina Bürki
(IN BRIEF) The EQT Foundation has opened a global call for proposals under its Breakthrough Science grants program, offering grants from €25,000 to €100,000 to researchers focused on addressing critical female health challenges with deeptech solutions. The initiative seeks to … Read the full press release
Posted in Business, Healthcare, Industrial, Investment, Pharma & Biotech, Sweden
Tagged 000, accredited institutions, Autoimmune Disorders, Breakthrough Science, cardiovascular diseases, commercialization, deeptech, diagnostics, endometriosis, EQT Foundation, female health challenges, financial support, global call for proposals, grants program, gynecological conditions, low-resource settings, maternal health, mentorship, Research & Innovation, therapeutics, Women’s Health
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?